Advances in oral therapy for type 2 diabetes.
Davis, S N
Advances in oral therapy for type 2 diabetes. [electronic resource] - Postgraduate medicine May 2000 - 16-20 p. digital
Publication Type: Journal Article; Review
1941-9260
10.3810/pgm.5.15.2000.suppl4.23 doi
Acarbose--therapeutic use
Administration, Oral
Blood Glucose--drug effects
Carbamates--therapeutic use
Cyclohexanes--therapeutic use
Diabetes Mellitus, Type 2--drug therapy
Drug Combinations
Drug Therapy, Combination
Glycated Hemoglobin--drug effects
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--adverse effects
Insulin--metabolism
Insulin Secretion
Insulin-Secreting Cells--drug effects
Metformin--therapeutic use
Nateglinide
Phenylalanine--analogs & derivatives
Piperidines--therapeutic use
Randomized Controlled Trials as Topic
Thiazolidinediones--therapeutic use
United States--epidemiology
Weight Gain--drug effects
Advances in oral therapy for type 2 diabetes. [electronic resource] - Postgraduate medicine May 2000 - 16-20 p. digital
Publication Type: Journal Article; Review
1941-9260
10.3810/pgm.5.15.2000.suppl4.23 doi
Acarbose--therapeutic use
Administration, Oral
Blood Glucose--drug effects
Carbamates--therapeutic use
Cyclohexanes--therapeutic use
Diabetes Mellitus, Type 2--drug therapy
Drug Combinations
Drug Therapy, Combination
Glycated Hemoglobin--drug effects
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--adverse effects
Insulin--metabolism
Insulin Secretion
Insulin-Secreting Cells--drug effects
Metformin--therapeutic use
Nateglinide
Phenylalanine--analogs & derivatives
Piperidines--therapeutic use
Randomized Controlled Trials as Topic
Thiazolidinediones--therapeutic use
United States--epidemiology
Weight Gain--drug effects